Pharmexcil sees $1.2 billion export hit from EU ban

India's business loss arising from the European Union's ban on 700 generic drugs is likely to be around USD 1.2 billion, says industry body Pharmexcil.

'Pharma exports may have grown 2.2% to $15.2 bn in FY15'

Indian pharma exports are estimated to have grown, but at a slower pace of 2.2 percent to about USD 15.2 billion during the financial year ended March 2015 against USD 14.9 billion in the previous fiscal, said a top official of Pharmexcil, an export promotion body, Monday.

In Ebola-hit West Africa, Indian pharma to showcase its wares

Even as the Ebola virus disease outbreak in West Africa is causing worldwide concern, the Indian pharmaceutical industry is set to expand its footprint in the region with its first ever exhibition outside India.

Pharma market grew by 6.8% at Rs 6,370 cr in May 2013

Despite weak market conditions, the domestic pharmaceutical market reported growth of 6.8 percent at Rs 6,370 crore for the month of May 2013, IMS Health said in its report here.

Pharma exports expected to touch Rs 75,000 cr in 2012-13

Pharmaceutical exports of Indian companies in 2012-13 is expected to touch Rs 75,000 crore, up by 25 percent over last year, a top official of trade body Pharmexcil said here Thursday.

Pharma exports grew over 23% in 2011-12: Pharmexcil

Indian pharma exports grew by 23.34 percent in the last fiscal, Pharmaceuticals Export Promotion Council of India (Pharmexcil) said Wednesday.